ZORAIDA MENDEZ | CANCER CARE ONCOLOGY

The COC Protocol is a combination regime of four commonly prescribed medications, each with evidence of metabolically-based anticancer activity, and well understood safety profiles. These medications are: metformin, atorvastatin, doxycycline, and mebendazole. Some of the studies which support the use of the COC Protocol as an adjunctive therapy alongside current standard treatments for breast cancer will be discussed. This evidence mainly comes from laboratory studies, large epidemiological studies (which investigate links between taking medications and breast cancer outcomes in groups of individuals), and early stage clinical trials.

To register, visit: https://us02web.zoom.us/webinar/register/WN_vqmWIrOCQliEUNENQQurWw